CTNNB1 and adrenal cortex carcinoma: We performed experiments on the NCI-H295R human ACC cell line, which harbors an activating S45P CTNNB1 mutation [11] and demonstrates high levels of Wnt/β-catenin activity compared to Y1 ACC cells (Supplementary Figure S3A).